31
Views
2
CrossRef citations to date
0
Altmetric
Review Article

Microparticles with neuroactive agents

, &
Pages 343-362 | Received 27 Jan 1995, Accepted 17 Feb 1995, Published online: 27 Sep 2008

References

  • AEBISCHER, P., WINN, S. R., and GALLETTI, P. M., 1988, Transplantation of neural tissue in polymer capsules. Brain Research, 448, 364–368.
  • AEBISCHER, P., TRESCO, P. A., WINN, S. R., GREENE, L. A., and JAEGAR, B. C., 1991, Long-term cross-species brain transplantation of a polymer-encapsulated dopamine-secreting cell line. Experimental Neurology, 111, 269–275.
  • AEBISCHER, P., GODDARD, M., SIGNORE, A. P., and TIMPSON, R. L., 1994, Functional recovery in hemiparkinsonian primates transplanted with polymer-encapsulated PC12 cells. Experimental Neurology, 126, 151–158.
  • BANGA, A. K., and CHIEN, Y. W., 1988, Systemic delivery of therapeutic peptides and proteins. International Journal of Pharmaceutics, 48, 15-5O.
  • BJORKLUND, A., LINDVALL, O., ISACSON, O., BRUNDIN, P., WICTORIN, K., STRECKER, R. E., CLARKE, D. J., and DUNNETT, S. B., 1987, Mechanism of action of intracerebral neuronal implants: studies on nigral and striatal grafts of the lesioned striatum. Trends in Neurosciences, 10, 509–516.
  • BODMEIER, R. H., OH, K. H., and CHEN, H., 1989, The effect of the addition of low molecular weight poly(dl-lactide) on drug release from biodegradable poly(dl-lactide) drug delivery systems. International Journal of Pharmaceutics, 51, 1–8.
  • BOHN, M., CUPIT, L., MARCIANO, F., and GASH, D. M., 1987, Adrenall medulla grafts enhance recovery of striatal dopaminergic fibers. Science, 237, 913–915.
  • CAMARATA, P. J., SURYANARAYANAN, R., TURNER, D. A., PARKER, R. G., and EBNER, T. J., 1992, Sustained release of nerve growth factor from biodegradable polymer microspheres. Neurosurgery, 30, 313–319.
  • CHU, C. C., 1985, Degradation phenomena of two linear aliphatic polyester fibre used in medicine and surgery. Polymerization, 26, 591–594.
  • CUTRIGHT, D. E., PEREZ, B., BEASLEY, J. D., LARSON, W. J., and POSEY, W. R., 1974, Degradation of poly(lactic acid) polymer and co-polymer of poly(glicolic acid). Oral Surgery, 37, 142–152.
  • DEASY, P. B., 1984, Microencapsulation and Related Drug Processes (Marcel Dekker, New York).
  • DONBROW, M. (Ed.), 1992, Microcapsules and nanoparticles in medicine and pharmacy (CRC Press, Boca Raton).
  • DURING, M. J., SABEL, B. A., FREESE, A., SALTZMAN, W. M., DEUTZ, A., ROTH, R. H., and LANCER, R., 1989, Controlled release of dopamine from a polymer brain implant: in vivo characterization. Annals of Neurology, 25, 351–356.
  • EMERICII, D. F., MCDERMOTT, P. E., KRUEGER, P. M., FRYDEL, B., SANBERG, P. R., and WINN, S. R., 1993, Polymer-encapsulated PC I 2 cells promote recovery of motor function in aged rats. Experimental Neurology, 122, 37–47.
  • FILIPOVIC-GRCIC, J., MAYSINGER, D., ZORC, B., and JALAENJAK, 1., 1995, Macromolecular prodrugs. IV. Alginate-chitosan microspheres of PHEA-L-dopa adduct. International Journal of Pharmaceutics, 116, 39–44.
  • FRESSE, A., SABEL, B. A., SALTZMAN, W. M., DURING, M. J., and LANCER, R., 1989, Controlled release of dopamine from a polymeric brain implant: in vitro characteriza-tion. Experimental Neurology, 103, 234–238.
  • GOOSEN, M. F. A., O'SHEA, G. M., GHARAPETIAN, H. M., CHOU, S., and SUN, A. M., 1985, Optimization of microencapsulation parameters: semipermeable microcapsules as a bioartificial pancreas. Biotechnology and Bioengineering, 27, 146-15O.
  • GOOSEN, M. F. A., 1987, Insulin delivery systems and the encapsulation of cells for medical and industrial use. Critical Reviews in Biocompatibility 3, edited by D. F. Williams (CRC Press, Boca Raton), pp. 1–24.
  • HARBAUGH, R. E., 1989, Novel CNS-directed drug delivery systems in Alzheimer's disease and other neurological disorders. Neurobiology of Aging, 10, 623–629.
  • HOFFMAN, D., WAHLBERG, L., and AEBISCHER, P., 1990, NGF released from a polymer matrix prevents loss of ChAT expression in basal forebrain neurons following a fimbria-fornix lesion. Experimental Neurology, 110, 39–44.
  • HOFFMAN, D., BREAKEFIELD, X. O., SHORT, M. P., and AEBISCHER, P., 1993, Transplantation of a polymer-encapsulated cell line genetically engineered to release NGF. Experimental Neurology, 122, 100–106.
  • HORELLOU, P., MARLIER, L., PRIVAT, A., and MALLET, J., 1990, Behavioural effect of engineered cells that synthesize L-Dopa or dropamin after grafting into the rat neostriatum. European Journal of Neurosciences, 2,116–119.
  • HORELLOU, P., BRUNDIN, P., KALEN, P., MALLET, J., and BJORKLUND, A., 1990a, In vivo release of DOPA and dopamine from genetically engineered cells grafted to the denervated rat striatum. Neuron, 5,393–402.
  • JAEGER, C. B., GREENE, L. A., TRESCO, P. A., WINN, S. R., and AEBISCHER, P., 1990, Polymer encapsulated dopaminergic cell lines as 'alternative neural grafts'. Progress in Brain Research, 82, 41–46.
  • JAEGER, C. B., AEBISCHER, P., TRESCO, P. A., WINN, S. R., and GREENE, L. A., 1992, Growth of tumor cell lines in macrocapsules: ultrastructure of encapsulated PC12 cells. journal of Neurocytology, 21, 469-48O.
  • JALIL, R., and NIxoN, J. R., 1990, Biodegradable poly(lactic acid) and poly(lactide-co-glycol-ide) microcapsules: problems associated with preprative techniques and release properties. Journal of Microencapsulation, 7, 297–325.
  • KING, G. A., DAUGULIS, A. J., FAULKNER, P., and GOOSEN, M. F. A., 1987, Alginate-polylysine microcapsules of controlled membrane molecular weight cutoff for mammalian cell culture engineering. Biotechnology Progress, 3, 231-24O.
  • KONDO, T., 1992, Interaction of microcapsules with blood components. Microcapsules and Nanoparticles in Medicine and Pharmacy, edited by M. Donbrow (CRC Press, Boca Raton), pp. 167–181.
  • Li, Q., DUNN, T., GRANDMAISON, E. W., and GOOSEN, M. F. A., 1992, Applications and properties of chitosan. Journal of Bioactive and Compatible Polymers, 7, 370–397. Um, F., and SUN, A. M., 1980, Microencapsulated islets as bioartificial pancreas. Science, 210, 908-91O.
  • LINDVALL, O., BRUNDIN, P., WIDNER, H., REHNCRONA, S., GUSTAVI I, B., FRANKOWIAC, R., LEENDERS, K., SAWLE, G., ROTH WELL, J., MARSDEN, D., and BJORKLUND, A., 1989, Grafts of fetal dopmine neurons survive and improve motor function in Parkinson's disease. Science, 247, 574–577.
  • LINDHARDT, R. J., 1989, Biodegradable polymers for controlled release of drugs. Controlled Release of Drugs Polymers and Aggregate Systems, edited by M. Rosoff (VCH, New York), pp. 53–95.
  • MCRAE-DEGUERARCE, A., HJORTH, S., DILLON, D. L., MASON, D. W., and TICE, T. R., 1988, Implantable microencapsulate dopamine (DA): A new approach for slow-release DA delivery into brain tissue. Neuroscience Letters, 92, 303–309.
  • McRAE, A., HJORTH, S., MASON, D. W., DILLON, D. L., and TICE, T. R., 1991, Microencap-sulated dopamine (DA)-induced restitution of function in 6-0HDA-denervated rat striatum in vivo: comparison between two microsphere excipients. Journal of Neural Transplantation and Plasticity, 2,165–173.
  • McRAE, A., and DAHLSTRöM, A., 1994, Transmitter-loaded polymeric microspheres induce regrowth of dopaminergic nerve terminals in strata of rats with 6-0H-DA induced parkinsonims. Neurochemistry International, 25, 27–33.
  • MATHIOWITZ, E., and LANGER, R., 1992, Polyanhydride microspheres as drug delivery systems. Microcapsules and Nonoparticles in Medicine and Pharmacy, edited by M. Donbrow (CRC Press, Boca Raton), pp. 99–123.
  • MAYSINGER, D., JALgENJAK, V., STOLNIK, S., GAROFALO, L., CUELLO, A. C., and JALgENJAK, I., 1989, Microencapsulated monosialoganglioside GM1: physical properties and in vivo effects. Journal of Microencapsulation, 6, 35–42.
  • MAYSINGER, D., GAROFALO, L., JALgENJAK, I., and CUELLO, A. C., 1989a, Effects of microencapsulated monosialoganglioside GM1 on cholinergic neurons. Brain Research, 496, 165–172.
  • MAYSINGER, D., JALgENJAK, I., and CUELLO, A. C., 1992, Microencapsulated nerve growth factor: effects on the forebrain neurons following devascularizing cortical lesions. Neuroscience Letters, 140, 71–74.
  • MAYSINGER, D., JALgENJAK, V., STOLNIK, S., and JALgENJAK, I., 1992a, Release of L-dopa from HSA microspheres into the rat brain: in vitro and in vivo characterization by microdialysis. Microencapsulation of Drugs, edited by T. L. Whately (Harwood Academic Publishers, Chur), pp. 269–275.
  • MAYSINGER, D., PICCARDO, P., FiLmovit-GRti, J., and CUELLO, A. C., 1993, Microencap-sulation of genetically engineered fibroblasts secreting nerve growth factor. Neurochem-istry International, 23, 123–129.
  • MAYSINGER, D., FiLiPovit-GRtit, J., and CUELLO, A. C., 1993a, Effects of coencapsulated NGF and GM1 in rats with cortical lesions. NeuroReport, 4, 971–974.
  • MAYSINGER, D., PICCARDO, P., LIBERINI, P., JALgENJAK., I., and CUELLO, A. C., 1994, Encapsulated genetically engineered fibroblasts: release of nerve growth factor and effects in vivo on recovery of cholinergic markers after devascularizing cortical lesions. Neurochemistry International, 24, 495–503.
  • MENEI, P., DANIEL, V., MONTERO-MENEI, C., BROUILLARD, M., POUPLARD-BARTHELAIX, A., and BENOIT, J. P., 1993, Biodegradation and brain tissue reaction to poly(D-L lactide-co-glycolide) microspheres. Biomaterials, 14, 470–478.
  • MILLER, R. A., BRADY, J. M., and CUTRIGHT, D. E., 1977, Degradation rates of oral reabsorbable implants (PLA-PGA), rate modified with change in poly(lactide-co-gly- coside) copolymer ratios. Journal of Biomedical Material Research, 11, 711–719.
  • PASSL, W. J., 1989, Synthetic polymers in modern pharmacy. Progress in Polymer Science, 44, 629–677.
  • PEARLMAN, R., and NGUYEN, T., 1992, Pharmaceutics of protein drugs. Journal of Pharmacy and Pharmacology, 44 (Suppl. 1), 178–185.
  • POLK, A., AMSDEN, B., DE YAO, K., PENG, T., and GOOSEN, M. F. A., 1994, Controlled release of albumin from chitosan-alginate microcapsules. Journal of Pharmaceutical Sciences, 83, 178–185.
  • POWELL, E. M., SOBARZO, M. R., and SALTZMAN, W. M., 1990, Controlled release of nerve growth factor from a polymeric implant. Brain Research, 515, 309–311.
  • SMIDSROD, O., and SKJAK-BRAEK, G., 1990, Alginate as immobilization matrix for cells. TIB TECH, 8, 71–78.
  • SPENLEHAUER, G.,VERT, M., BENOIT, J. P., and BODDAERT, A., 1989, In vitro and in vivo degradation of poly(D-L lactide-glycolide) type microspheres made by solvent evaporation method. Biomaterials, 10, 557–563.
  • SUN, A. M., and O'SHEA, G. M., 1986, Microencapsulation of living cells—a long-term delivery system. Advances in Drug Delivery Systems, edited by S. W. Kim and B. Anderson (Elsevier, Amsterdam), pp. 137–141.
  • SUN, A. M., VACEK, I., and TAI, I., 1992, Microencapsulation of living cells and tissues. Microcapsules and Nanoparticles in Medicine and Pharmacy, edited by M. Donbrow (CRC Press, Boca Raton), pp. 315–322.
  • TAMARGO, R. J., EPSTEIN, J. I., REINI1ARD, C. S., CHASIN, M., and BREM, H., 1989, Brain biocompatibility of a biodegradable, controlled-release polymer in rats. Journal of Biomedical Material Research, 23, 253–266.
  • THIES, C., 1992, Formation of degradable drug-loaded microparticles by in-liquid drying processes. Microcapsules and Nanoparticles in Medicine and Pharmacy, edited by M. Donbrow (CRC Press, Boca Raton), pp. 47–71.
  • TICE, T. R., and COWSAR, D. R., 1984, Biodegradable controlled-release parental systems. Pharmaceutishe Technology, 8, 26–35.
  • TRESCO, P. A., WINN, S. R., TAN, S., JAEGER, C. B., GREENE, L. A., and AEBISCHER, P., 1992, Polymer-encapsulated PC12 cells: long-term survival and associated reduction in lesion-induced rotational behaviour. Cell Transplantation, 1, 255–264.
  • TRESCO, P. A., 1994, Encapsulated cells for sustained neurotransmitter delivery to the central nervous system. Journal of Controlled Release, 28, 253–258.
  • ULUDAG, H., and SEFTON, M. V., 1992, Metabolic activity of CHO fibroblasts in HEMA-MMA microcapsules. Biotechnology and Bioengineering, 39, 672–678.
  • VANDENBOSSCHE, G. M. R., BRACKE, M. E., CUVELIER, C. A., BORTIER, H. E., MAREEL, M. M., and REMON, J. P., 1993, Host reaction against alginate-polylysine microcapsules containing living cells. Journal of Pharmacy and Pharmacology, 45, 121–125.
  • WINN, S. R., WAHLBERG, L., TRESCO, P. A., and AEBISCHER, P., 1989, An encapsulated dopamine-releasing polymer alleviates experimental parkinsonism in rats. Experimental Neurology, 105, 244-25O.
  • WINN, S. R., TRESCO, P. A., ZIELINSKI, B., GREENE, L. A., JAEGER, C. B., and AEBISCHER, P., 1991, Behavioral recovery following intrastiatal implantation of microencapsulated PC12 cells. Experimental Neurology, 113, 322–329.
  • WOERLY, S., ULBRICH, K., CHYTRY, V., SMETANA, K., PETROVICKY, P., RIHOVA, B., and MORASSUTTI, D. J., 1993, Synthetic polymer matrices for neural cell transplantation. Cell Transplantation, 2, 229–239.
  • YAPEL, A. F., 1985, Albumin microspheres: Heat and chemical stabilization. Methods in Enzymology, 112, 3–18.
  • YOLLES, S., LEAFE, T., SARTORI, M., TORKELSON, M., and WARD, L., 1976, Controlled release of biologically active agents. Controlled Release Polymeric Formulations, edited by D. R. Paul and F. W. Harris (Am. Chem. Soc), pp. 123–134.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.